Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development

Fetal Exposure to Antidepressants and Normal Milestone Development at 6 and 19 Months of Age

(2010) L. H. Pedersen et al.   PEDIATRICS

Major Depression and Antidepressant Treatment: Impact on Pregnancy and Neonatal Outcomes

(2009) K. L. Wisner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Selective Serotonin Reuptake Inhibitor Exposure In Utero and Pregnancy Outcomes

(2009) Najaaraq Lund et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Are selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmur

(2009) Paul Merlob et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Antidepressant Use During Pregnancy and the Risk of Preterm Delivery and Fetal Growth Restriction

(2009) Sengwee Toh et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

New perspectives on the neurodevelopmental effects of SSRIs

(2009) Judith R. Homberg et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Association of Apgar score at five minutes with long-term neurologic disability and cognitive function in a prevalence study of Danish conscripts

(2009) Vera Ehrenstein et al.   BMC Pregnancy and Childbirth

Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: Population-based study

(2008) Tim F. Oberlander et al.   BRITISH JOURNAL OF PSYCHIATRY

Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands

(2007) Marian K. Bakker et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY